The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca (Inst); Clovis Oncology (Inst); MSD Oncology (Inst)
Research Funding - PharmaMar (Inst)
Expert Testimony - Clovis Oncology (Inst); Onxeo (Inst); Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche; Tesaro
Victoria: A multicentric, randomized, open-label, phase I/II of mTOR inhibitor (VISTUSERTIB) combined with anastrozole in patients with hormone receptor-positive advanced/metastatic endometrial cancer—A CLIPP program INCA in collaboration with GINECO group.
 
Pierre-Etienne Heudel
Honoraria - Amgen; AstraZeneca (Inst); Mylan; Novartis (Inst); Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - Novartis (Inst); Seagen
Research Funding - Fresenius (Inst)
Travel, Accommodations, Expenses - Lilly; Novartis; Pfizer; Roche
 
Jean-Sebastien Frenel
Consulting or Advisory Role - Amgen; AstraZeneca; Daiichi Sankyo Europe GmbH; GlaxoSmithKline; Lilly; Novartis; Novocure; Pfizer; Pierre Fabre; Roche
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo Europe GmbH; Lilly; Novartis; Pfizer; Roche
 
Cécile Dalban
No Relationships to Disclose
 
Fernando Bazan
Honoraria - AstraZeneca; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Florence Joly
Honoraria - Amgen; Astellas Pharma; AstraZeneca; GlaxoSmithKline; Ipsen; Roche; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; GlaxoSmithKline; Ipsen; Janssen; MSD Oncology; Pfizer; Sanofi
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Ipsen; Janssen; Roche
 
Antoine Arnaud
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche
 
Cyril Abdeddaim
Consulting or Advisory Role - GlaxoSmithKline
 
Annick Chevalier
No Relationships to Disclose
 
Paule Augereau
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Novartis; Pfizer
 
Patricia Pautier
No Relationships to Disclose
 
Camille Chakiba
No Relationships to Disclose
 
Benoit You
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Clovis Oncology; Daiichi Sankyo Europe GmbH; ECS PROGASTRIN; GlaxoSmithKline; Immunomedics; LEK; Novartis; Roche/Genentech; TESARO
Research Funding - Clovis Oncology (Inst); Merck Serono (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bayer; BMS; MSD Oncology; Roche/Genentech
 
Laurence Lancry Lecomte
Travel, Accommodations, Expenses - AstraZeneca; Celgene; MSD; Pfizer; PharmaMar
 
Gwenaelle Garin
No Relationships to Disclose
 
Virginie MArcel
No Relationships to Disclose
 
Jean-Jacques Diaz
No Relationships to Disclose
 
Isabelle Treilleux
No Relationships to Disclose
 
David Pérol
Honoraria - AstraZeneca; IPSEN; Lilly; Novartis; Pierre Fabre; Roche
Research Funding - MSD Avenir (Inst); MSD Avenir (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Michel Fabbro
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; Tesaro/GSK (Inst)
Travel, Accommodations, Expenses - Roche
 
Isabelle Laure Ray-Coquard
Honoraria - Abbvie; Advaxis; Amgen; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; DECIPHERA; Genmab; GlaxoSmithKline; MERSANA; MSD Oncology; OxOnc; Pfizer; PharmaMar; Roche; Tesaro
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Clovis Oncology; Deciphera; Genmab; GlaxoSmithKline; Mersana; Mersana; MSD Oncology; Pfizer; PharmaMar; Roche; Tesaro
Research Funding - BMS; MSD Oncology
Travel, Accommodations, Expenses - Advaxis; AstraZeneca; BMS; Clovis Oncology; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche; Tesaro
(OPTIONAL) Uncompensated Relationships - Arcagy-Gineco; French National Cancer Institute (INCA)